Ignite Creation Date:
2024-07-17 @ 11:01 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495021
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-03
Brief Title:
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care
Sponsor:
Geisinger Clinic
Organization:
Geisinger Clinic
Study Overview
Official Title:
OMT and Respiratory Illness
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to see Osteopathic Manipulative Therapy or OMT can aid in treating patients being seen for respiratory illness and associated symptoms The hypothesis is that the addition of OMT therapy alongside other standard care such as a medication can help lessen patient symptoms sooner than just other treatment alone and the duration of the condition will shorten as well
Detailed Description:
Respiratory illness is a common complaint seen routinely in primary care Illness is a common cause of reduced productivity general discomfort and missed time from work Osteopathic manual therapy OMT and the lymphatic pump is used frequently among osteopathic physicians to treat patients with infections Many osteopathic physicians have anecdotal reports of patient having reduced respiratory symptoms reported in follow up care from patients OMT is a useful low-cost treatment and can help reduce duration of illness symptoms improve patients comfort and accelerate their return to their productive lives
There have been few studies on an outpatient level quantifying this improvement Previous research in other models have showed benefits of OMT to help reduce illness Studies in a rat model have shown reduced S pneumonia bacterial load in the lung after lymphatic pump Additional rat studies demonstrated improved benefit with lymphatic pump in addition to antibiotic treatment In a dog model lymphatic pump has been shown to increase cytokine flow to the thoracic duct In humans OMT has shown to improve secretory immunoglobulin A levels in stressed student population In the hospital setting OMT for patients with pneumonia has shown to decrease hospital length of stay 5 OMT has been a known useful additional treatment to pneumonia however there are few prospective studies on treatment of pneumonia and respiratory illness in the outpatient setting
This study is designed to support evidence that patients with a recent diagnosis of upper respiratory illness sinusitis bronchitis or pneumonia who receive lymphatic pump OMT experience reduced severity and length of symptoms After informed consent patients of ages 65-100 years of age who are diagnosed with a respiratory illness will be randomized to either standard care without OMT or standard care plus OMT Patients will be provided an electronic survey to quantify symptoms of cough congestion and malaise on both the day of illness diagnosis followed by the same survey 5 days later Survey results comparing day of diagnosis and 5 days later will be recorded in a secure database and analyzed with appropriate statistical testing The goal of this study is to show how the lymphatic pump can reduce both severity and duration of symptoms related to respiratory illness
There have been few studies on an outpatient level quantifying this improvement Previous research in other models have showed benefits of OMT to help reduce illness Studies in a rat model have shown reduced S pneumonia bacterial load in the lung after lymphatic pump Additional rat studies demonstrated improved benefit with lymphatic pump in addition to antibiotic treatment In a dog model lymphatic pump has been shown to increase cytokine flow to the thoracic duct In humans OMT has shown to improve secretory immunoglobulin A levels in stressed student population In the hospital setting OMT for patients with pneumonia has shown to decrease hospital length of stay 5 OMT has been a known useful additional treatment to pneumonia however there are few prospective studies on treatment of pneumonia and respiratory illness in the outpatient setting
This study is designed to support evidence that patients with a recent diagnosis of upper respiratory illness sinusitis bronchitis or pneumonia who receive lymphatic pump OMT experience reduced severity and length of symptoms After informed consent patients of ages 65-100 years of age who are diagnosed with a respiratory illness will be randomized to either standard care without OMT or standard care plus OMT Patients will be provided an electronic survey to quantify symptoms of cough congestion and malaise on both the day of illness diagnosis followed by the same survey 5 days later Survey results comparing day of diagnosis and 5 days later will be recorded in a secure database and analyzed with appropriate statistical testing The goal of this study is to show how the lymphatic pump can reduce both severity and duration of symptoms related to respiratory illness
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None